Targeted Oncology

In a First, FDA Approves Monthly Subcutaneous Amivantamab for EGFR+ NSCLC

FDA approves monthly subcutaneous amivantamab plus lazertinib for EGFR-mutated advanced NSCLC, cutting clinic time and ...

Ostarine: The performance-enhancing drug giving anti-doping agencies a headache

A drug designed to help cancer patients rebuild wasting muscles has become one of the most contentious substances in elite sport—and the scientist who discovered it now spends more time trying to stop ...
The Indianapolis Star

As Indiana weighs syringe exchange law, new data shows shifting risks

Monroe County's syringe exchange program distributed 40% fewer syringes in 2025 compared to its peak in 2020. Indiana lawmakers are considering a bill to extend the state's syringe exchange programs ...
Medscape

Most Clinicians Know About Self-Injectable Contraception, but Few Prescribe It, Study Finds

When Lindsey Boynton was offered the option to give herself her birth control shot at home, she was surprised the option even existed. The method — self-injected subcutaneous depot medroxyprogesterone ...
Reuters

Lilly will have supply of new weight loss pill for many countries, exec says

SAN FRANCISCO, Jan 12 (Reuters) - Eli Lilly's (LLY.N), opens new tab research and development head said on Monday the company will have plenty of supply to launch its much-anticipated new weight-loss ...
Hosted on MSN

New concerns about what happens when people stop using weight loss injectable drugs

A new study finds those people re-gain the weight about four times faster than is normally seen with traditional weight loss programs involving diet and exercise. Trump reaction to watching video of ...
Plastics Today

It’s Awards Season for Injection Molders, Too

Are you a master molder? Were you involved in the production of an innovative plastic part? Then, you might have a shot at winning an Impact Award, a new program that recognizes innovation, ...
MarketWatch

PAI Pharma Acquires Nivagen Pharmaceuticals, Expanding Domestic Sterile Injectable Manufacturing and Expanding Ready-To-Use ("RTU") Product Offering in the Hospital Market

The MarketWatch News Department was not involved in the creation of this content. GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of ...
Becker's Hospital Review

Drug shortage relief targeted in US injectable supply deal

PAI Pharma has acquired Nivagen Pharmaceuticals in a move it said was aimed at expanding the domestic supply of sterile injectable drugs. Nivagen operates a recently built aseptic manufacturing ...
BioSpace

PAI Pharma Acquires Nivagen Pharmaceuticals, Expanding Domestic Sterile Injectable Manufacturing and Expanding Ready-To-Use (“RTU”) Product Offering in the Hospital Market

GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of Olympus Partners and a leading U.S. developer, manufacturer and marketer of oral liquid ...
CNBC

First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.

American patients can now receive the first-ever GLP-1 pill for weight loss from Novo Nordisk, marking a new chapter of obesity treatment in the U.S. The cash prices for the drug, called the Wegovy ...